» Articles » PMID: 33987823

Influence of Swimming Program on the Blood Pressure of Pregnant Hypertensive Rats and Their Fetuses

Overview
Journal Reprod Sci
Publisher Springer
Date 2021 May 14
PMID 33987823
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

The hypertension incidence and its complication on pregnant women are growing and can lead to adverse consequences on their fetuses. However, it is known that regular exercise practice can be healthful to hypertensive pregnant women but harmful to fetal growth. So, the objective of this study was to evaluate the effects of exercise beginning before pregnancy or during pregnancy on the maternal blood pressure and reproductive outcome and on the fetal development of spontaneously hypertensive rats (SHR). Pregnant SHR were randomly distributed into three experimental groups: (1) SHR-Control, non-exercised; (2) SHR-Ex0, rats submitted to physical exercise (swimming program) from day zero to 20 of pregnancy; (3) and SHR-ExPr, rats submitted to swimming program before and during pregnancy. At end of pregnancy (day 21), the rats were anesthetized, and reproductive parameters and fetal development were assessed. Blood pressure was reduced at the end of pregnancy in all the groups. Regardless of swimming exposure time, there was reduced maternal weight gain. The exercise decreased fetal weight at term pregnancy, with a higher percentage of small for gestational age (SGA) fetuses and lower number ossification sites, indicating intrauterine growth restriction (IUGR). In conclusion, our findings provide insight to support that swimming exercise in pregnant SHR impairs fetal development, causing IUGR and visceral malformations. Therefore, the indication of physical exercise must be defined very carefully, as it can compromise fetal development.

Citing Articles

The Ethanolic Extract of Kunth Is Teratogenic and Interferes with the Ossification Process of Swiss Mice Fetuses.

Nunes R, Neves S, Salustriano F, Vilela M, do Nascimento V, Arunachalam K Pharmaceuticals (Basel). 2023; 16(3).

PMID: 36986529 PMC: 10051201. DOI: 10.3390/ph16030430.

References
1.
Kearney P, Whelton M, Reynolds K, Muntner P, Whelton P, He J . Global burden of hypertension: analysis of worldwide data. Lancet. 2005; 365(9455):217-23. DOI: 10.1016/S0140-6736(05)17741-1. View

2.
Mills K, Bundy J, Kelly T, Reed J, Kearney P, Reynolds K . Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation. 2016; 134(6):441-50. PMC: 4979614. DOI: 10.1161/CIRCULATIONAHA.115.018912. View

3.
Fraser A, Nelson S, Macdonald-Wallis C, Cherry L, Butler E, Sattar N . Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children. Circulation. 2012; 125(11):1367-80. PMC: 3323835. DOI: 10.1161/CIRCULATIONAHA.111.044784. View

4.
Vest A, Cho L . Hypertension in pregnancy. Curr Atheroscler Rep. 2014; 16(3):395. DOI: 10.1007/s11883-013-0395-8. View

5.
Ohkuchi A, Hirashima C, Takahashi K, Suzuki H, Matsubara S . Prediction and prevention of hypertensive disorders of pregnancy. Hypertens Res. 2016; 40(1):5-14. DOI: 10.1038/hr.2016.107. View